LQDA - Liquidia Technologies Inc
Liquidia Technologies Inc Logo

LQDA - Liquidia Technologies Inc

https://www.liquidia.com
Buy Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-09 (Snapshot)

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and markets various products for the unmet needs of patients in the United States. The company is headquartered in Morrisville, North Carolina.

52W High
$29.94
52W Low
$8.75
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
0.23
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-9.43
EV/Revenue (<3 favorable)
129.94
P/S (TTM) (<3 favorable)
128.54
P/B (<3 favorable)
163.53
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
13.61%
Institutions (25–75% balanced)
70.58%
Shares Outstanding
86,092,000
Float
60,852,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
19,322,000
Gross Profit (TTM)
13,389,000
EPS (TTM)
-1.82
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-4.24%
ROE (TTM) (>15% strong)
-3.89%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
1.42
Momentum
Bearish momentum
Value
1.5484
Previous
1.8673
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025